SAB Biotherapeutics, Inc. (SABS): SCHEDULE 13D/A filed Mar 23, 2026

Form type

SCHEDULE 13D/A

Filing date

Mar 23, 2026

Accession number

0001346824-26-000079

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)